These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9871443)

  • 41. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum.
    Zigmond MJ; Castro SL; Keefe KA; Abercrombie ED; Sved AF
    Amino Acids; 1998; 14(1-3):57-62. PubMed ID: 9871442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presynaptic facilitation of dopamine release through D,L-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors on synaptosomes from the rat striatum.
    Desce JM; Godeheu G; Galli T; Artaud F; Chéramy A; Glowinski J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):692-8. PubMed ID: 1682483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals.
    Johnson KM; Jeng YJ
    Can J Physiol Pharmacol; 1991 Oct; 69(10):1416-21. PubMed ID: 1685693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2.
    Avshalumov MV; Chen BT; Marshall SP; Peña DM; Rice ME
    J Neurosci; 2003 Apr; 23(7):2744-50. PubMed ID: 12684460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum.
    Krebs MO; Trovero F; Desban M; Gauchy C; Glowinski J; Kemel ML
    J Neurosci; 1991 May; 11(5):1256-62. PubMed ID: 1851217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
    Malva JO; Carvalho AP; Carvalho CM
    Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMDA receptor blockade increases in vivo striatal dopamine synthesis and release in rats and mice with incomplete, dopamine-depleting, nigrostriatal lesions.
    Richard MG; Bennett JP
    J Neurochem; 1995 May; 64(5):2080-6. PubMed ID: 7722491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats.
    Pollack AE; St Martin JL; MacPherson AT
    Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
    Kosowski AR; Cebers G; Cebere A; Swanhagen AC; Liljequist S
    Psychopharmacology (Berl); 2004 Aug; 175(1):114-23. PubMed ID: 15088078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
    Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
    Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors.
    Vidal L; Durán R; Faro LF; Campos F; Cervantes RC; Alfonso M
    Toxicology; 2007 Sep; 238(2-3):140-6. PubMed ID: 17624650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat nucleus accumbens nerve terminals.
    Grilli M; Summa M; Salamone A; Olivero G; Zappettini S; Di Prisco S; Feligioni M; Usai C; Pittaluga A; Marchi M
    Neuropharmacology; 2012 Oct; 63(5):916-26. PubMed ID: 22771975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of [3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors.
    Werling LL; Jacocks HM; McMahon PN
    J Pharmacol Exp Ther; 1990 Oct; 255(1):40-5. PubMed ID: 1698972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMDA receptors in nucleus accumbens modulate stress-induced dopamine release in nucleus accumbens and ventral tegmental area.
    Doherty MD; Gratton A
    Synapse; 1997 Jul; 26(3):225-34. PubMed ID: 9183812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens.
    Schilström B; Nomikos GG; Nisell M; Hertel P; Svensson TH
    Neuroscience; 1998 Feb; 82(3):781-9. PubMed ID: 9483535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presynaptic ionotropic glutamate receptors modulate GABA release in the mouse dorsal motor nucleus of the vagus.
    Xu H; Smith BN
    Neuroscience; 2015 Nov; 308():95-105. PubMed ID: 26343294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons.
    Wu YN; Shen KZ; Johnson SW
    Br J Pharmacol; 1999 Jul; 127(6):1422-30. PubMed ID: 10455292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Halothane and isoflurane increase spontaneous but reduce the N-methyl-D-aspartate-evoked dopamine release in rat striatal slices: evidence for direct presynaptic effects.
    Keita H; Henzel-Rouellé D; Dupont H; Desmonts JM; Mantz J
    Anesthesiology; 1999 Dec; 91(6):1788-97. PubMed ID: 10598623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.